Sean Cao is the founder of ENSEM Therapeutics. ENSEM Therapeutics has raised $67M in total funding. Latest round: Series A. Based in Cambridge, USA.
Sean Cao is the CEO of ENSEM Therapeutics, a biotechnology company founded in 2021. The company, based in Massachusetts, develops small molecule medicines for difficult-to-drug targets, particularly in oncology, utilizing its Kinetic Ensemble platform.
Full founder directory · Investor directory · Company funding database · Fundraising library